BR100 Increased By (1.16%)
BR30 Increased By (1.76%)
KSE100 Increased By (0.66%)
KSE30 Increased By (0.73%)
BECO 6.04 Increased By ▲ 0.27 (4.68%)
BML 53.25 Increased By ▲ 0.25 (0.47%)
BOP 34.33 Increased By ▲ 0.34 (1%)
CNERGY 8.18 Increased By ▲ 0.07 (0.86%)
DCL 12.40 Increased By ▲ 0.20 (1.64%)
FCCL 54.10 Increased By ▲ 1.27 (2.4%)
FCSC 5.22 Increased By ▲ 0.15 (2.96%)
FFL 18.10 Increased By ▲ 0.15 (0.84%)
FNEL 1.30 Increased By ▲ 0.01 (0.78%)
HUMNL 11.00 Increased By ▲ 0.12 (1.1%)
KEL 8.13 Increased By ▲ 0.11 (1.37%)
KOSM 5.37 Decreased By ▼ -0.15 (-2.72%)
MLCF 88.00 Increased By ▲ 1.49 (1.72%)
NBP 187.00 Increased By ▲ 1.84 (0.99%)
PACE 10.67 Increased By ▲ 0.09 (0.85%)
PAEL 40.11 Increased By ▲ 0.69 (1.75%)
PIAHCLA 26.16 Decreased By ▼ -0.06 (-0.23%)
PIBTL 17.36 Increased By ▲ 0.69 (4.14%)
PPL 232.40 Increased By ▲ 4.22 (1.85%)
PRL 35.07 Increased By ▲ 0.39 (1.12%)
PTC 67.16 Increased By ▲ 1.83 (2.8%)
SEARL 91.00 Increased By ▲ 0.87 (0.97%)
SSGC 27.20 Increased By ▲ 0.60 (2.26%)
TELE 8.64 Increased By ▲ 0.36 (4.35%)
THCCL 59.55 Increased By ▲ 1.05 (1.79%)
TPLP 8.75 Increased By ▲ 0.53 (6.45%)
TREET 24.75 Increased By ▲ 0.22 (0.9%)
TRG 71.50 Increased By ▲ 1.79 (2.57%)
WAVES 10.00 Increased By ▲ 0.06 (0.6%)
WTL 1.27 Decreased By ▼ -0.01 (-0.78%)
World

AstraZeneca says it will work with Dutch over vaccine queries

  • "Regulatory authorities in the UK, European Union, the World Health Organization have concluded that the benefits of using our vaccine to protect people from this deadly virus significantly outweigh the risks across all adult age groups," a spokesman for AstraZeneca said in a statement.
Published April 2, 2021 Updated April 2, 2021 09:37pm
By

LONDON: AstraZeneca said on Friday it was working with Dutch authorities to address any questions they had after the Netherlands temporarily suspended use of its COVID-19 vaccine for people under 60 following the death of a woman who had received a shot.

"Regulatory authorities in the UK, European Union, the World Health Organization have concluded that the benefits of using our vaccine to protect people from this deadly virus significantly outweigh the risks across all adult age groups," a spokesman for AstraZeneca said in a statement.

"Tens of millions of people have now received our vaccine across the globe. The extensive body of data from two large clinical datasets and real-world evidence demonstrate its effectiveness, reaffirming the role the vaccine can play during this public health crisis."

Comments

Comments are closed for this article.